China Jo-Jo Drugstores Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017 - 2008
Revenue	148.81	164.39	133.13	117.33	107.55	Upgrade
Revenue Growth (YoY)	-9.48%	23.48%	13.47%	9.09%	11.90%	Upgrade
Cost of Revenue	114.53	127.87	103.89	91.8	82.44	Upgrade
Gross Profit	34.28	36.52	29.24	25.53	25.11	Upgrade
Selling, General & Admin	44.85	39.06	33.91	31.9	25.98	Upgrade
Other Operating Expenses	10.36	0.15	4.17	0.63	0	Upgrade
Operating Expenses	55.21	39.21	38.08	32.53	25.98	Upgrade
Operating Income	-20.93	-2.69	-8.84	-7	-0.88	Upgrade
Interest Expense / Income	0.07	0.26	0.46	0.7	0	Upgrade
Other Expense / Income	-0.25	-0.86	-1.2	-1.91	-0.08	Upgrade
Pretax Income	-20.74	-2.09	-8.09	-5.8	-0.79	Upgrade
Income Tax	0.39	1.1	0.03	0.02	0.13	Upgrade
Net Income	-21.14	-3.19	-8.12	-5.81	-0.93	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	Upgrade
Shares Change	193.06%	2.38%	24.27%	13.41%	14.64%	Upgrade
EPS (Basic)	-41.40	-18.40	-47.80	-43.20	-7.20	Upgrade
EPS (Diluted)	-41.40	-18.40	-47.80	-43.20	-7.20	Upgrade
Free Cash Flow	-3.58	-5.69	-0.57	-8.32	-12.88	Upgrade
Free Cash Flow Per Share	-7.03	-32.68	-3.35	-60.85	-106.85	Upgrade
Gross Margin	23.04%	22.21%	21.97%	21.76%	23.35%	Upgrade
Operating Margin	-14.06%	-1.64%	-6.64%	-5.97%	-0.81%	Upgrade
Profit Margin	-14.20%	-1.94%	-6.10%	-4.95%	-0.86%	Upgrade
Free Cash Flow Margin	-2.41%	-3.46%	-0.43%	-7.09%	-11.98%	Upgrade
EBITDA	-19.96	-0.57	-5.88	-3.02	0.88	Upgrade
EBITDA Margin	-13.41%	-0.35%	-4.42%	-2.57%	0.82%	Upgrade
Depreciation & Amortization	0.72	1.26	1.75	2.08	1.68	Upgrade
EBIT	-20.68	-1.83	-7.63	-5.1	-0.79	Upgrade
EBIT Margin	-13.90%	-1.11%	-5.73%	-4.35%	-0.74%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).